ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Time Is Money
The role of duration in the valuation of early-stage biopharma assets in this In Vivo article.
Proving Real World Value
In the July/Aug issue of PME, Ramita Tandon discusses how to use real world intelligence to demonstrate drug efficacy and cost-effectiveness.
Domestic Research Enhancement Act Changing Clinical Trials Outsourcing
How will the act change outsourcing in the U.S?
The Burden of Choice
Clinical Oncologist Daily on ICON's decision to invest in a Cancer Moonshot project using quantum computing.
ICON Oncology’s Opinion of How We Can Reach for the Stars With a Moonshot
ICON experts contribute to this article in Clinical Oncologist Daily on ICON's decision to invest in a Cancer Moonshot project using quantum computing.
APAC is the fastest growing market for CRO industry
clinical trials in the APAC region.
Effective Sponsor-CRO Collaboration
Commentary in PharmaVOICE on effective sponsor-CRO collaboration.
ICON Recognised for Excellence in Vaccine Development
Article on the future of drug development and the central role that precision medicine will play in global healthcare.
Predatory Journals Are Back in the Firing Line
Learn how to spot a predatory journal with these tips from PubsHub.
Overcoming Four Challenges to Successful Rare Disease Drug Development
Article relating to overcoming challenges to greatly improve the chances for a successful rare or “orphan” drug trial.